Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy

Background  Human tissue kallikreins (KLKs) are a family of 15 trypsin‐like or chymotrypsin‐like secreted serine proteases (KLK1–KLK15). Multiple KLKs have been quantitatively identified in normal stratum corneum (SC) and sweat as candidate desquamation‐related proteases.

[1]  T. Kishi,et al.  Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[2]  E. Diamandis,et al.  A Potential Role for Multiple Tissue Kallikrein Serine Proteases in Epidermal Desquamation* , 2006, Journal of Biological Chemistry.

[3]  L. Chao,et al.  The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction , 2006, Biological chemistry.

[4]  E. Diamandis,et al.  Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs) , 2006, Biological chemistry.

[5]  E. Diamandis,et al.  Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more , 2006, Biological chemistry.

[6]  E. Diamandis,et al.  Quantification of eight tissue kallikreins in the stratum corneum and sweat. , 2006, The Journal of investigative dermatology.

[7]  M. Walden,et al.  hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6 , 2005, The British journal of dermatology.

[8]  E. Diamandis,et al.  Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. , 2005, The Journal of investigative dermatology.

[9]  Y. Hanakawa,et al.  Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI) , 2005, Biological chemistry.

[10]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[11]  E. Diamandis,et al.  Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases , 2005, The British journal of dermatology.

[12]  E. Diamandis,et al.  Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression* , 2005, Journal of Biological Chemistry.

[13]  T. Kishi,et al.  Enzymatic profiling of human kallikrein 14 using phage-display substrate technology , 2005, Biological chemistry.

[14]  A. Ishida-Yamamoto,et al.  LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. , 2005, The Journal of investigative dermatology.

[15]  F. Marceau,et al.  The kallikrein-kinin system: current and future pharmacological targets. , 2005, Journal of pharmacological sciences.

[16]  M. Brattsand,et al.  A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.

[17]  A. Sonnenberg,et al.  Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity , 2005, Nature Genetics.

[18]  A. Gottlieb.  Psoriasis: emerging therapeutic strategies , 2005, Nature Reviews Drug Discovery.

[19]  M. Blaber,et al.  Distinct promoters regulate tissue‐specific and differential expression of kallikrein 6 in CNS demyelinating disease , 2004, Journal of neurochemistry.

[20]  M. Simon,et al.  Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. , 2004, The Journal of investigative dermatology.

[21]  Moses Rodriguez,et al.  Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Ishida-Yamamoto,et al.  Epidermal lamellar granules transport different cargoes as distinct aggregates. , 2004, The Journal of investigative dermatology.

[23]  M. Ghazizadeh,et al.  Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. , 2004, The Journal of investigative dermatology.

[24]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[25]  P. Bellavite,et al.  Neutrophil Functions and IL-8 in Psoriatic Arthritis and in Cutaneous Psoriasis , 1998, Inflammation.

[26]  G. Yousef,et al.  Complex formation between human kallikrein 13 and serum protease inhibitors. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[27]  C. Bodemer,et al.  LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. , 2003, Human molecular genetics.

[28]  E. Diamandis,et al.  Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. , 2003, Biochemical and biophysical research communications.

[29]  K. Mitsudo,et al.  Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. , 2003, Biochemistry.

[30]  Toshio Hakoshima,et al.  Role of Loop Structures of Neuropsin in the Activity of Serine Protease and Regulated Secretion* , 2002, The Journal of Biological Chemistry.

[31]  K. Saijoh,et al.  Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. , 2002, The Journal of investigative dermatology.

[32]  P. Elliott,et al.  Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. , 2002, The Journal of clinical investigation.

[33]  G. Yousef,et al.  Human Tissue Kallikreins: A New Enzymatic Cascade Pathway? , 2002, Biological chemistry.

[34]  M. Simon,et al.  Refined Characterization of Corneodesmosin Proteolysis during Terminal Differentiation of Human Epidermis and Its Relationship to Desquamation* , 2001, The Journal of Biological Chemistry.

[35]  G. Yousef,et al.  The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.

[36]  M. Salis,et al.  Local Delivery of Human Tissue Kallikrein Gene Accelerates Spontaneous Angiogenesis in Mouse Model of Hindlimb Ischemia , 2001, Circulation.

[37]  K. Wang,et al.  Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. , 2000, Gene.

[38]  C. Bodemer,et al.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.

[39]  M. Brattsand,et al.  Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? , 2000, The Journal of investigative dermatology.

[40]  N. Seidah,et al.  Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides 1 Published on the World Wide Web on 17 August 1999. 1 , 1999, Brain Research.

[41]  M. Steinhoff,et al.  Proteinase‐activated receptor‐2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase , 1999, Experimental dermatology.

[42]  M. Reinecke,et al.  LEKTI, a Novel 15-Domain Type of Human Serine Proteinase Inhibitor* , 1999, The Journal of Biological Chemistry.

[43]  T. Egelrud,et al.  Stratum corneum chymotryptic enzyme in psoriasis , 1999, Archives of Dermatological Research.

[44]  E. Bröcker,et al.  Differential Expression of GRO-α and IL-8 mRNA Psoriasis: A Model for Neutrophil Migration and Accumulation In Vivo , 1996 .

[45]  A. Baici,et al.  Antileukoprotease Inhibits Stratum Corneum Chymotryptic Enzyme , 1996, The Journal of Biological Chemistry.

[46]  H. Tagami,et al.  The role of two endogenous proteases of the stratum corneum in degradation of desmoglein‐1 and their reduced activity in the skin of ichthyotic patients , 1996, The British journal of dermatology.

[47]  E. Bröcker,et al.  Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. , 1996, The Journal of investigative dermatology.

[48]  J. Van Damme,et al.  Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.

[49]  D. Steiner.  Proteolytic processing. , 1986, Science.